Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III trial of artificial bear bile capsule for acute pharyngitis
CTR20261066Phase 3Active
- Sponsor
- Institute of Medical Biotechnology, Chinese Academy of Medical Sciences
- Start
- Apr 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of artificial bear bile capsule in acute pharyngitis (3 arms), sponsored by Institute of Medical Biotechnology, Chinese Academy of Medical Sciences. Primary endpoint: Sore throat disappearance rate. Started Apr 2026; status: active.
02
Drugs
artificial bear bile capsule
03
Conditions
acute pharyngitis
Beyond the preview
Go deeper on CTR20261066.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20261066.